Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Regulatory News

Date Source Headline
19th Jun 2017 7:00 am RNS Satellite Symposium at EAACI 2017
6th Jun 2017 7:00 am RNS Directorate changes
2nd Jun 2017 12:55 pm RNS Holding(s) in Company
13th Apr 2017 7:00 am RNS Issue of Equity
5th Apr 2017 7:15 am RNS Hardman Research: Development across portfolio
29th Mar 2017 7:00 am RNS Interim Results for six months ended 31 Dec 2016
16th Mar 2017 7:00 am RNS First Patient in Pivotal Phase III Birch Study
9th Mar 2017 7:00 am RNS Notice of Interim Results
14th Feb 2017 7:00 am RNS House Dust Mite Allergy Vaccine Gains CTA Approval
8th Feb 2017 7:00 am RNS Directorate Change
1st Feb 2017 7:00 am RNS Positive Efficacy & Safety Data in Peanut Vaccine
20th Jan 2017 7:15 am RNS Hardman Research: Investment driving market share
19th Jan 2017 7:00 am RNS Trading Update
30th Dec 2016 2:31 pm RNS Grant of Awards
24th Nov 2016 5:23 pm RNS Result of AGM
2nd Nov 2016 7:00 am RNS EU Patent Office grants patent for MCT
27th Oct 2016 1:10 pm RNS Issue of equity in respect of exercise of options
24th Oct 2016 1:35 pm RNS Annual Report and Accounts
10th Oct 2016 7:00 am RNS New data from novel adjuvant system
3rd Oct 2016 11:28 am RNS Issue of equity in respect of exercise of options
29th Sep 2016 12:40 pm RNS Director/PDMR Shareholding
28th Sep 2016 7:00 am RNS Director/PDMR Shareholding
26th Sep 2016 11:59 am RNS Director/PDMR Shareholding
26th Sep 2016 10:46 am RNS Hardman Research: Performance drives market share
26th Sep 2016 7:00 am RNS Allergy Therapeutics Preliminary Results
20th Sep 2016 4:58 pm RNS Issue of equity in respect of exercise of options
5th Sep 2016 7:00 am RNS Notice of Preliminary Results
13th Jul 2016 7:00 am RNS Trading Update
8th Jul 2016 7:00 am RNS Results of mite immunotherapy Acarovac PlusT
27th Jun 2016 7:00 am RNS Findings from mEEC dose range finding study G204
13th Jun 2016 7:00 am RNS Allergy hosts Satellite Symposium at EAACI
10th Jun 2016 7:00 am RNS Appointment of Finance Director
9th May 2016 7:00 am RNS Positive Phase II Data
23rd Mar 2016 9:02 am RNS Issue of equity in respect of options exercise
17th Mar 2016 7:00 am RNS Board Change
11th Mar 2016 4:36 pm RNS Grant of Options under Long Term Incentive Plan
8th Mar 2016 7:00 am RNS Interim Results for the six months ended 31/12/15
24th Feb 2016 7:30 am RNS Hardman & Co Research Report: Development Progress
23rd Feb 2016 7:00 am RNS Notice of Interim Results
18th Feb 2016 7:00 am RNS Patient enrolment completed in US Phase IIb study
FTSE 100 Latest
Value8,556.64
Change15.67